Search
The CEO of Rejuvenate Bio on the company's liver directed gene therapy program targeting FGF21
- blonca9
- Jun 6, 2024
- 1 min read
Daniel Oliver describes how Rejuvenate believes this program could have utility against arrhythmias and heart failure in both humans and dogs.